Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (869)
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
4,227
Price
$65.73
Total Value
$277.84K
Shares Held After
36,150
% of Holdings
10.5%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$65.38
Total Value
$490.35K
Shares Held After
415,330
% of Holdings
1.8%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
7,449
Price
$66.02
Total Value
$491.78K
Shares Held After
58,555
% of Holdings
11.3%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
53,644
Price
$16.01
Total Value
$858.84K
Shares Held After
3,197,619
% of Holdings
1.6%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
3,300
Price
$40.00
Total Value
$132.00K
Shares Held After
1,491,934
% of Holdings
0.2%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
3,000
Price
$40.00
Total Value
$120.00K
Shares Held After
405,775
% of Holdings
0.7%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
492
Price
$59.69
Total Value
$29.37K
Shares Held After
31,080
% of Holdings
1.6%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,548
Price
$59.03
Total Value
$386.55K
Shares Held After
31,572
% of Holdings
17.2%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.56
Total Value
$277.51K
Shares Held After
416,836
% of Holdings
4.4%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
47,814
Price
$44.51
Total Value
$2.13M
Shares Held After
3,482,888
% of Holdings
1.4%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
47,814
Price
$44.51
Total Value
$2.13M
Shares Held After
3,482,888
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,159
Price
$89.97
Total Value
$374.19K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
5,251
Price
$90.00
Total Value
$472.60K
Shares Held After
61,202
% of Holdings
7.9%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
1,347
Price
$90.00
Total Value
$121.23K
Shares Held After
50,195
% of Holdings
2.6%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
600
Price
$4.97
Total Value
$2.98K
Shares Held After
631,496
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
43,129
Price
$4.96
Total Value
$213.83K
Shares Held After
3,664,440
% of Holdings
1.2%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
8,000
Price
$41.07
Total Value
$328.56K
Shares Held After
57,500
% of Holdings
12.2%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
2,800
Price
$4.96
Total Value
$13.89K
Shares Held After
682,432
% of Holdings
0.4%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
3,000
Price
$55.00
Total Value
$165.00K
Shares Held After
122,694
% of Holdings
2.4%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
1,600
Price
$4.96
Total Value
$7.93K
Shares Held After
266,996
% of Holdings
0.6%
10x Genomics, Inc. (TXG)
Saxonov Serge — Director
Shares
5,000
Price
$24.56
Total Value
$122.78K
Shares Held After
1,167,273
% of Holdings
0.4%
Travere Therapeutics, Inc. (TVTX)
Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Shares
21,977
Price
$41.07
Total Value
$902.60K
Shares Held After
42,353
% of Holdings
34.2%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
6,750
Price
$42.12
Total Value
$284.31K
Shares Held After
37,500
% of Holdings
15.3%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
26,000
Price
$41.07
Total Value
$1.07M
Shares Held After
44,250
% of Holdings
37.0%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
37,500
Price
$65.23
Total Value
$2.45M
Shares Held After
1,182,504
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
957
Price
$581.50
Total Value
$556.50K
Shares Held After
40,513
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,675
Price
$580.55
Total Value
$2.13M
Shares Held After
41,470
% of Holdings
8.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,580
Price
$579.65
Total Value
$915.84K
Shares Held After
45,145
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,164
Price
$578.41
Total Value
$673.27K
Shares Held After
46,725
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,360
Price
$577.62
Total Value
$785.57K
Shares Held After
47,889
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$575.89
Total Value
$46.07K
Shares Held After
49,249
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
404
Price
$575.25
Total Value
$232.40K
Shares Held After
49,329
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$574.25
Total Value
$160.79K
Shares Held After
49,733
% of Holdings
0.6%
Alzamend Neuro, Inc. (ALZN)
AULT MILTON C III — Director
Shares
108,388
Price
$1.00
Total Value
$108.90K
Shares Held After
116,648
% of Holdings
92.9%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
74,350
Price
$0.77
Total Value
$57.25K
Shares Held After
104,498
% of Holdings
71.1%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
7,215
Price
$41.93
Total Value
$302.52K
Shares Held After
112,491
% of Holdings
6.0%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
7,239
Price
$41.93
Total Value
$303.52K
Shares Held After
117,913
% of Holdings
5.8%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
9
Price
$41.07
Total Value
$369.63
Shares Held After
125,152
% of Holdings
0.0%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
7,215
Price
$41.93
Total Value
$302.52K
Shares Held After
111,996
% of Holdings
6.1%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
37,500
Price
$41.07
Total Value
$1.54M
Shares Held After
119,211
% of Holdings
23.9%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — CHIEF COMMERCIAL OFFICER
Shares
7,215
Price
$41.93
Total Value
$302.52K
Shares Held After
138,608
% of Holdings
4.9%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
92,460
Price
$3.64
Total Value
$336.55K
Shares Held After
397,106
% of Holdings
18.9%
Genprex, Inc. (GNPX)
LONGNECKER BRENT M — Director
Shares
10
Price
$1.23
Total Value
$12.30
Shares Held After
0
% of Holdings
100.0%
Genprex, Inc. (GNPX)
LONGNECKER BRENT M — Director
Shares
8
Price
$1.23
Total Value
$9.84
Shares Held After
9,157
% of Holdings
0.1%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
153,735
Price
$15.97
Total Value
$2.46M
Shares Held After
3,251,263
% of Holdings
4.5%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
900
Price
$45.51
Total Value
$40.96K
Shares Held After
235,244
% of Holdings
0.4%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
7,921
Price
$44.58
Total Value
$353.11K
Shares Held After
236,144
% of Holdings
3.2%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
14,130
Price
$43.66
Total Value
$616.99K
Shares Held After
244,065
% of Holdings
5.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
8,000
Price
$17.64
Total Value
$141.12K
Shares Held After
605,471
% of Holdings
1.3%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
2,000
Price
$2.80
Total Value
$5.60K
Shares Held After
29,375
% of Holdings
6.4%
Showing 151–200 of 869 transactions (page 4 of 18)